APA (7th ed.) Citation

Fokkens, W. J., Bachert, C., Hopkins, C., Marglani, O., Praestgaard, A., Nash, S., . . . Jacob‐Nara, J. A. (2024). Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: Results from the SINUS‐52 trial. Clinical & Translational Immunology, 13(6), 1. https://doi.org/10.1002/cti2.1511

Chicago Style (17th ed.) Citation

Fokkens, Wytske J., et al. "Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps Irrespective of Gender: Results from the SINUS‐52 Trial." Clinical & Translational Immunology 13, no. 6 (2024): 1. https://doi.org/10.1002/cti2.1511.

MLA (9th ed.) Citation

Fokkens, Wytske J., et al. "Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps Irrespective of Gender: Results from the SINUS‐52 Trial." Clinical & Translational Immunology, vol. 13, no. 6, 2024, p. 1, https://doi.org/10.1002/cti2.1511.